138 related articles for article (PubMed ID: 15846123)
1. Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity.
Lynch ED; Gu R; Pierce C; Kil J
Anticancer Drugs; 2005 Jun; 16(5):569-79. PubMed ID: 15846123
[TBL] [Abstract][Full Text] [Related]
2. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
Lynch ED; Gu R; Pierce C; Kil J
Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
[TBL] [Abstract][Full Text] [Related]
3. Effect of protective agents against cisplatin ototoxicity.
Rybak LP; Husain K; Morris C; Whitworth C; Somani S
Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
[TBL] [Abstract][Full Text] [Related]
4. Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats.
Yoshida M; Iizuka K; Terada A; Hara M; Nishijima H; Akinori ; Shimada ; Nakada K; Satoh Y; Akama Y
Tohoku J Exp Med; 2000 Aug; 191(4):209-20. PubMed ID: 11038013
[TBL] [Abstract][Full Text] [Related]
5. Ebselen-mediated protection from single and repeated noise exposure in rat.
Lynch ED; Gu R; Pierce C; Kil J
Laryngoscope; 2004 Feb; 114(2):333-7. PubMed ID: 14755214
[TBL] [Abstract][Full Text] [Related]
6. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
7. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model.
Lorito G; Hatzopoulos S; Laurell G; Campbell KC; Petruccelli J; Giordano P; Kochanek K; Sliwa L; Martini A; Skarzynski H
Med Sci Monit; 2011 Aug; 17(8):BR179-186. PubMed ID: 21804453
[TBL] [Abstract][Full Text] [Related]
9. Chronotolerance for cisplatin ototoxicity in the rat.
Bielefeld EC; Markle A; DeBacker JR; Harrison RT
Hear Res; 2018 Dec; 370():16-21. PubMed ID: 30253329
[TBL] [Abstract][Full Text] [Related]
10. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy.
Li G; Frenz DA; Brahmblatt S; Feghali JG; Ruben RJ; Berggren D; Arezzo J; Van De Water TR
Neurotoxicology; 2001 Apr; 22(2):163-76. PubMed ID: 11405249
[TBL] [Abstract][Full Text] [Related]
11. Ototoxicity. Amelioration by protective agents.
Rybak LP; Somani S
Ann N Y Acad Sci; 1999 Nov; 884():143-51. PubMed ID: 10842591
[TBL] [Abstract][Full Text] [Related]
12. D-methionine provides excellent protection from cisplatin ototoxicity in the rat.
Campbell KC; Rybak LP; Meech RP; Hughes L
Hear Res; 1996 Dec; 102(1-2):90-8. PubMed ID: 8951454
[TBL] [Abstract][Full Text] [Related]
13. Ebselen attenuates cochlear damage caused by acoustic trauma.
Pourbakht A; Yamasoba T
Hear Res; 2003 Jul; 181(1-2):100-8. PubMed ID: 12855368
[TBL] [Abstract][Full Text] [Related]
14. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system.
Husain K; Morris C; Whitworth C; Trammell GL; Rybak LP; Somani SM
Mol Cell Biochem; 1998 Jan; 178(1-2):127-33. PubMed ID: 9546591
[TBL] [Abstract][Full Text] [Related]
15. Ebselen prevents noise-induced excitotoxicity and temporary threshold shift.
Yamasoba T; Pourbakht A; Sakamoto T; Suzuki M
Neurosci Lett; 2005 Jun; 380(3):234-8. PubMed ID: 15862892
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic Diltiazem-Chitosan Hydrogel as an Otoprotectant Against Cisplatin-Induced Ototoxicity in a Mouse Model.
Naples JG; Ruckenstein MJ; Singh J; Cox BC; Li D
Otol Neurotol; 2020 Jan; 41(1):115-122. PubMed ID: 31746818
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of ebselen on radiocontrast-induced nephrotoxicity.
Ozgur T; Tutanc M; Zararsiz I; Motor S; Ozturk OH; Yaldiz M; Kurtgoz OY
Ren Fail; 2012; 34(8):991-7. PubMed ID: 22880804
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer.
Cloven NG; Re A; McHale MT; Burger RA; DiSaia PJ; Rose GS; Campbell KC; Fan H
Anticancer Res; 2000; 20(6B):4205-9. PubMed ID: 11205249
[TBL] [Abstract][Full Text] [Related]
19. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats.
Mundhe NA; Kumar P; Ahmed S; Jamdade V; Mundhe S; Lahkar M
Int Immunopharmacol; 2015 Sep; 28(1):634-42. PubMed ID: 26247680
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model.
Hughes AL; Hussain N; Pafford R; Parham K
Otolaryngol Head Neck Surg; 2014 Jan; 150(1):115-20. PubMed ID: 24233060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
